MeiraGTx Holdings plc

MGTX Nasdaq CIK: 0001735438

Company Information

Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
Business Address 655 THIRD AVENUE, NEW YORK, NY, 10017
Mailing Address 655 THIRD AVENUE, NEW YORK, NY, 10017
Phone 646-860-7985
Fiscal Year End 1231
EIN 981448305

Financial Overview

FY2025

$138.18M
Stockholders' Equity

Recent SEC Filings

Form Type Date Filed Document
10-K Annual financial report March 30, 2026 View on SEC
8-K Current report of material events March 26, 2026 View on SEC
4 Insider stock transaction report March 24, 2026 View on SEC
4 Insider stock transaction report February 23, 2026 View on SEC
4 Insider stock transaction report February 23, 2026 View on SEC
4 Insider stock transaction report February 23, 2026 View on SEC
4 Insider stock transaction report February 23, 2026 View on SEC
4 Insider stock transaction report February 23, 2026 View on SEC
SCHEDULE 13G Passive beneficial ownership (>5%) February 13, 2026 View on SEC
SCHEDULE 13G/A Passive ownership amendment February 13, 2026 View on SEC

Annual Reports

10-K March 30, 2026
  • Vertically integrated manufacturing capabilities with commercial-grade authorization in the UK.
  • Proprietary 'riboswitch' technology acts as a biological dimmer switch for precise gene therapy control.
View Analysis

Insider Trading

SELL 1 insiders 1 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 2836)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.